A controlled smoking cessation trial for substance-dependent inpatients.

Burling, Thomas A.; Burling, Andrea Seidner; Latini, David

doi:10.1037/0022-006x.69.2.295

Cited by 121 publications

(97 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The authors would also note that the impact of linking treatments for smoking cessation with those targeted at other drug abstinence remains unclear. Such combined treatment efforts, although helpful for nicotine, may exert a negative impact on the drug treatment [12]. Drug or alcohol treatment outcomes could be compromised if too much emphasis is placed on quitting smoking as a marker of success.…”

Section: Discussionmentioning

confidence: 95%

“…There is a critical need to develop effective smoking treatments for this population [11]. Burling et al [12] recently conducted a clinical trial comparing the efficacy of two smoking treatments designed for newly recovering drug and alcohol-dependent smokers in a residential rehabilitation program (n=200) for homeless veterans. The first treatment (multicomponent smoking treatment [MST]) used multiple intensive smoking cessation interventions, including contingency contracting and relapse prevention training, to address the high level of nicotine dependence found in this population.…”

Section: Introductionmentioning

confidence: 98%

See 1 more Smart Citation

Current perspectives on smoking cessation among substance abusers

Sullivan

Covey²

2002

Curr Psychiatry Rep

View full text Add to dashboard Cite

The prevalence of nicotine dependence among alcohol or other substance abusers is extremely high, and surveys have revealed that many patients in drug or alcohol treatment programs are interested in smoking cessation. However, smoking cessation has not been a traditional focus in clinical interventions for this population. Recent evidence from clinical trials among individuals abusing alcohol, marijuana, cocaine, or opioids have shown the following: 1) smokers with a past but not current history of alcohol dependence have a similar rate of success compared with non-alcoholic smokers; 2) tobacco abstinence does not increase alcohol relapse; 3) continued smoking adversely affects treatment for marijuana dependence; 4) patterns of cocaine and nicotine use are interrelated; 5) smoking cessation rates among opioid-dependent individuals are several times lower than in the general US population. Smoking cessation is indicated for substance dependent persons already in recovery and may protect against relapse to the illicit drug of abuse.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Introductionmentioning

confidence: 98%

Current perspectives on smoking cessation among substance abusers

Sullivan

Covey²

2002

Curr Psychiatry Rep

View full text Add to dashboard Cite

show abstract

“…These findings, however, contrast a recent meta-analysis of 19 randomized controlled trials of smoking cessation interventions for persons in treatment for or recovery from an addiction that found no detrimental effect on substance use outcomes and suggested a possible benefit (Prochaska et al 2004). For example, Burling et al (2001) conducted a randomized controlled trial of two multicomponent smoking cessation treatment interventions compared to usual care among 150 participants in residential treatment for drug or alcohol dependence. Continuous smoking abstinence rates were significantly higher for the two smoking cessation treatment groups compared to usual care and no adverse effects on alcohol abstinence outcomes were observed.…”

Section: Discussionmentioning

confidence: 99%

Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment

Kodl²,

Willenbring

et al. 2008

Drug and Alcohol Dependence

View full text Add to dashboard Cite

The Timing of Alcohol and Smoking Cessation (TASC) Study tested the optimal timing of smoking cessation treatment in an alcohol dependent population. Previously reported results suggest that providing concurrent smoking cessation treatment adversely affects alcohol outcomes. The purpose of this analysis was to investigate whether there are ethnic differences in alcohol and tobacco outcomes among a diverse sample of alcohol dependent smokers using data from the TASC trial in which 499 participants were randomized to either concurrent (during alcohol treatment) or delayed (6 months later) smoking intervention. This analysis focused on smokers of Caucasian (n = 381) and African American (n = 78) ethnicity. Alcohol outcomes included 6-months sustained alcohol abstinence rates and time to first use of alcohol post-treatment. Tobacco outcomes included 7-day point prevalence smoking abstinence. Random effects logistic regression analysis was used to investigate intervention group and ethnic differences in the longitudinally assessed alcohol outcomes. Alcohol abstinence outcomes were consistently worse in the concurrent group than the delayed group among Caucasians, but this was not the case for African Americans. No significant ethnic differences were observed in smoking cessation outcomes. Findings from this analysis suggest that concurrent smoking cessation treatment adversely affects alcohol outcomes for Caucasians but not necessarily for African Americans.

show abstract

“…On any given day, approximately 1 million Americans are in treatment for alcohol and other drug problems. 11 Research in this new field suggests that many substance abuse treatment patients are highly interested in quitting smoking, [12][13][14][15][16][17][18][19][20] that evidence-based treatment achieves long-term quit rates of 5-14%, 13,[21][22][23][24] and that quitting smoking does not threaten abstinence from other drugs of abuse, but might actually promote it. [6][7][8][9] Some substance abuse treatment facilities are beginning to do so.…”

Section: Introductionmentioning

confidence: 99%

Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States

Friedmann

Jiang

Richter

2008

Journal of Substance Abuse Treatment

114

View full text Add to dashboard Cite

Objective-To estimate the prevalence and determinants of cigarette smoking cessation treatment in U.S. outpatient substance abuse treatment (OSAT) units. Results-Of OSAT programs in the U.S., 41% offer smoking cessation counseling or pharmacotherapy; 38% offer individual/group counseling and 17% provide quit-smoking medication. In multivariate models, hospital affiliation, service breadth, the priority given to physical health, availability of medication to treat addictive problems, assessment of cigarette smoking, and greater perception of the proportion of patients that smoke were associated with delivery of smoking cessation services. Program size and medical staffing also influenced availability of quit-smoking medication. Methods-ProgramConclusions-Of U.S. OSAT programs, two-in-five offer behavioral treatment for smoking cessation, but fewer than one in five provide access to pharmacotherapy. Substance abuse treatment programs that are medically-oriented, provide more comprehensive services, and recognize the burden of tobacco smoking among their patients are more likely to deliver evidencebased smoking cessation services.

show abstract

A controlled smoking cessation trial for substance-dependent inpatients.

Cited by 121 publications

References 29 publications

Current perspectives on smoking cessation among substance abusers

Current perspectives on smoking cessation among substance abusers

Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment

Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States

Contact Info

Product

Resources

About